Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jane A. Gross currently holds 24,000 shares of aTYR PHARMA INC (LIFE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jane A. Gross has been a net neutral trader of LIFE stock. They have purchased $0 and sold $0 worth of shares.
Jane A. Gross's most recent insider trade was on May 22, 2024, when they sold 24,000 shares at $0.00 per share.
Jane A. Gross serves as Executive at aTYR PHARMA INC (LIFE). They have executed 16 insider transactions totaling $0 over their tenure at the company.
Jane A. Gross holds the position of Executive at aTYR PHARMA INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Jane A. Gross has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Jane A. Gross was on Aug 1, 2017, when they sold $18.4K worth of APVO shares. This transaction involved 10,076 shares at $1.83 per share.
Jane A. Gross currently owns 24,000 shares of aTYR PHARMA INC (LIFE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jane A. Gross's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jane A. Gross has 16 Form 4 filings on record as an insider at aTYR PHARMA INC.
Set alerts for Jane A. Gross and 40,000+ other insiders.